I am deeply honoured to be invited to give the 6th Duke Elder lecture. Duke-Elder is renowned for his many con tributions to ophthalmology, but first and foremost he was one of those rare ophthalmologists who saw the import ance of applying the scientific method to fundamental clinical problems and it was for his work as a scientist that he was elected Fellow of the Royal Society.
His major scientific interest was in the physiology of the ocular fluids but among his many other works he found time to make observations on uveitis. In the William McKenzie Memorial Lecture of 1930, he wrote that the 'pathology of vitreous inflammatory deposits was well understood'. 1 I' m not sure we would agree with that today. In a further paper in the Lancet concerning the prognosis of iritis and iridocyclitis, he stated, on the causation of uveitis, 'That most cases of ... uveitis are due to infective foci ... must be accepted as a fact , .2 However, he further observed that uveitis caused by an infectious agent was 'not necessarily due to enlodgement of toxin in the eye but mostly (represented) an allergic sensitisation response'. I think many of us would lean towards this view and I hope to show you here today that there are very sound scientific reasons why this concept probably still holds true. Inflammation of the eye and endogenous uveitis were included in an early English language textbook of ophthal mology by William McKenzie and several varieties of uveitis were described including sympathetic ophthalmia. However, even this paradigm of an autoimmune disease was not recognised as such since concepts of immunolog ical responses were poorly developed. McKenzie con sidered that the disease was transmitted by interocular neural transfer,3 and indeed there is evidence for such mechanisms in experimental models. 4 However the tem poral delay in second eye involvement could not be explained by such mechanisms.
Advances in the discipline of immunology led Paul Ehrlich5 to develop the concept of autoimmunity and to the notion that autoimmune responses were self-destruc tive (horror autotoxicus). However, he considered that autoantibodies were a normal occurrence and that some how they were inactivated by anti-autoantibodies, pre empting current network theory6 by some eighty-three years. Studies by Ulenhueth7 on autoantibodies to lens proteins supported Ehrlich' s views of regulatory controls of autoantibody responses. Somewhat later, sympathetic ophthalmia was recognised as an autoimmune disease and the putative antigen identified as melanin. 8 •9 This view held for many years and melanin is still implicitly regarded as the putative autoantigen for certain forms of posterior uveitis. 1 0 However, the importance of the retina in autoimmune intraocular inflammatory disease had already been highlighted in some early experimental stud ies by Hess and Romer in 1906 (for review see Faure 1 I ).
These initial studies in the field of autoimmunity fell into relative obscurity as the emphasis of immunological research was placed on immunochemistry and the struc ture of immunoglobulins, rather than on the functional role of the cells which produce these and many other mol ecules. It was not until the late 1950s that cellular aspects of immunology returned to the fore and that concepts of autoimmunity became established. Even today there is continuing controversy concerning the notion that uveitis may represent one form of autoimmune disease.
unrewarding, and despite associations with other systemic diseases, most cases of endogenous uveitis are considered idiopathic.
Posterior uveitis presents as a heterogeneous group of syndromes with no obvious relationship (Table I) ducin,22 all with the ability to induce posterior uveoretinitis, and a retinal pigment epithelial cell protein which produces a predominantly anterior uveitis. The best characterised of these antigens are S-antigen and IRBP; furthermore, the inflammatory response they induce in the eye has many similarities to human posterior uveitis. 23 Indeed, the response can be titrated by dose to produce a low-grade, subacute or chronic inflammation with pre dominantly Dalen-Fuchs type lesions (Fig. Id) , a moder ately severe inflammation with retinal vasculitis and extensive retinal damage (Fig. 1 e) , or a hyperacute type of response with massive exudative retinal detachment or retinal necrosis (Fig. 1 f) 
CURRENT CONCEPTS OF AUTOIMMUNITY
The concept of autoimmunity is fundamental to the immune system. Langman26 described the first law of the immune system as follows: 'Any mechanism of host defence against infectious agents which has the capacity to destroy macromolecules, requires a recognitive com ponent which can distinguish self from non-self.' Such a law holds true even for simple organisms, like amoeba.
Thus in the microcosm of a pool of rain water, an amoeba Diagrammatic representation of the respon se of a unicellular organism to atta ck by an intracellular pa thogen . Amoeba 1 would rec ognise 'self compon ents on amoeba 2 (represen ted by the arrow on the cell surface) which would in duce a sta te of anergy in amoeba 1. Amoeba 1 would rec ognise the sa me self ligand on amoeba 3 but the anergic respon se would be over-ridden by the respon se to the 'foreign ' ligan d (represented by the sta r) which con stitutes cell surface protein s transcribed from foreign DNA incorpora ted into the DNA of the host cell. Recognition of both self and foreign components is therefore necessa ry for removal of intracellular organisms.
will attack and remove a foreign invader, but it recognises a second amoeba as identical with itself and does not attempt to phagocytose that cell. The second amoeba thus has a mechanism (a receptor) which is recognised by the first amoeba (a ligand) and the response which is induced in the first amoeba is to 'switch off' its cellular machinery for phagocytosis. This is an important concept i.e. that the first interaction between receptor and ligand is to induce non-responsiveness or anergy in the cell. A mechanism such as this enables the cell to deal with extracellular foreign organisms without destroying itself. However, this system does not allow the cell to remove intracellular foreign organisms. An amoeba which has been infected by an intracellular pathogen such as a virus or parasite, still has its 'self' receptor and would evade attack by a healthy amoeba, despite the fact that the infected cell has incorporated the DNA from the invasive organism and is now expressing foreign antigens on its surface (Fig. 2) . A second ligand-receptor system is required which would override the anergy-inducing self recognition system and induce a phagocytic response in the cell, thereby removing the infected amoeba. Removal of intracellular foreign organisms therefore involves recognition of both self and foreign antigen. In this way simple unicellular organisms have become equipped to deal with both intra-and extra-cellular pathogens.
Similarly, higher organisms possess two systems for getting rid of foreign material: (a) one to deal with extra cellular foreign material (innate immunity e.g. polymor phonuclear leukocytes and macrophages, which act like simple phagocytes in recognising foreign material) and (b) one to deal with intracellular foreign organisms. The latter requires two recognition elements, one to recognise self antigens and a second to recognise foreign antigens expressed on the cell surface: this is manifested in higher order immune systems as the process of foreign antigen recognition in the context of self MHC antigens. This system has proved to be so efficient in responding to an infinite variety of foreign organisms that it evolved further towards two classes of effector cells: T cells which con tinue to respond to intracellular foreign organisms and B cells which produce factors (antibodies) that 'help' the innate system in the removal of extracellular organisms (Fig. 3 ). One particular cell type is central to this system i.e. the T helper cell, in that it 'arms' the two effector cells, the T cytotoxic cell and the B cell (Fig. 3 ). With time, the immune system has continued to develop in complexity and sophistication but the basic mechanisms described here have evolved due to the pressure of having to deal with both intra-and extra-cellular pathogens.
As indicated above, removal of extracellular organisms at its simplest approximation requires only a single recep tor system, but intracellular organisms require the recog nition of both self antigen and foreign antigen. The initial response of the immune cell on contact with antigen, therefore, is the induction of a non-responsive or anergic state induced by the' self' component of the antigen on the cell surface. It is only when the 'self' component of the antigen is complexed with a 'foreign' component that a second signal is induced and an immune response mounted; in contrast, if the second component of the com plex is also a autoantigen, then no second signal occurs and the cell remains in a state of anergy or tolerance. How ever if an autoantigen is not recognised as self (e.g. if there is cross-homology with foreign antigen to which the organism has recently become exposed as in the mech anism of molecular mimicry, see below), then an immune response is mounted to the autoantigen and autoimmune disease may occur.
As with all things biological, nothing is black and white. Thus all auto antigens induce some level of immune response depending on the nature of the antigen and its time of appearance during ontogeny. In this respect, it has proved difficult to demonstrate autoimmunity to retinal antigens in human uveitis since normal individuals possess autoreactive T and B cells to S antigen27•28 and to IRBp29 and the level of antibodies or cell-mediated immune responsiveness is often not significantly greater than that in the general population. This may partly be a reflection of the low level of antigen which is released from damaged retina into the system, but similar findings have been observed in other presumed autoimmune dis eases,3D except where the antigen is a component common to all cells such as DNA in SLE. 31 T and B cells are fundamentally different. B cells respond to soluble antigen and induce effects via soluble antibody. T cells on the other hand, respond to solid phase antigen on the surface of an antigen presenting cell (APC) and induce effects via cell-cell contact or by activating other cells e.g. effector/cytotoxic T cells or macrophages.
Interaction of an APC with a naive or resting T cell leads to autocrine activation of that T cell via the cytokine, inter leukin-2 (IL-2), and its receptor on the T cell, the IL-2 receptor (IL-2r). This produces clonal expansion in the T cell.
The central cell for all immune responses is the CD4+ T(helper) cell. Activation of a resting CD4+ T cell by an APC may induce that cell to differentiate in one of two ways: the T helper-l (Thl) cell secretes IL-2 and inter feron-y, which produces a delayed type hypersensitivity (DTH) response and activated macrophages; the T helper-2 (Th2) response leads to IL-4 production and acti vation of B cells with secretion of antibody (Fig. 4) .
Presentation of antigen by the APC occurs via recogni tion of the antigen bound to cell-surface major histocom patibility complex (MHC) antigen by a receptor on the T cell known as the T cell receptor (TCr) (Fig. 5) . CD4+ T cells recognise MHC Class II antigens while CD8+ T cells recognise MHC Class I antigen. Crystallography studies have shown that the antigenic peptide occupies a groove in the Class I molecule formed between a and � chains of the extracellular domain of the molecule (Fig. 5) . A similar relationship has been inferred for the Class II molecule. (Fig. 7a) . However, if the DC has been exposed to foreign antigen at a site of entry, the MHC Class II antigen becomes complexed with non self peptide which on interaction with the T cell in the lymph node induces an immune response (Fig. 7b) . The role of the DC is therefore to police those sites exposed to the external environment for the presence of invading foreign antigen.
As outlined above, immune responses to foreign anti gens and autoantigens occur by the same mechanisms. Recently, a re-examination of the normal uveal tract has revealed the presence of a large network of Class II posi tive cells which span the thickness of the choroid and send processes into intimate contact with RPE cells (Fig. 8a and b). In addition there is a mixed population of tissue and bone-marr ow derived macrophages which closely communicate with the dendritic cells ( Fig. 8c and d) .
There is therefore no need to invoke a mechanism of antigen presentation within the eye which involves aberrant expression of MHC Class II by resident cells. Instead, a mechanism can be envisaged whereby retinal antigens are phagocytosed during the normal process of outer segment renewal and peptides from these antigens are transported across the basal RPE into the cytoplasm of the closely associated DC. The DC then presents the peptide to randomly circulating autoreactive T cells which are pres ent normally in the circulation and would traffic through the choroid (Fig. 9) .
INFECTION AND AUTOIMMUNITY
A mechanism such as this, however, does not explain how autoimmune disease occurs. Rather, it is an explanation of how tolerance to retinal antigens is maintained since DCs (. : :i�· .
.�� Fig. 9 . Diagram of proposed in tera ction between 'immune cells' at the chorio-retina l interface. Dendritic cells closely in teracting with retina l pigmen t epithelial cells would be in a position to sa mple retinal antigens pa rtia lly proc essed by RP E cells; they would then be able to presen t these proc essed antigens to randomly circulating activated T cells.
presenting photoreceptor-derived autoantigens to circu lating autoreactive T cells would induce a state of anergy in the autoreactive cells, as outlined above for peripheral tolerance. Additional mechanisms must therefore be involved when an autoimmune response is induced.
Recently it has been shown that there is considerable amino acid sequence similarity (homology) between cer tain bacterial antigens and autoantigens. For instance, heat-shock proteins (HSP), which are present in all cells and have been highly conserved through evolution from prokaryotes to mammals, show 50% homology between the bacterial forms and human HSP. A marked increase in synthesis of HSP is induced in mammalian cells by stress, such as that associated with inflamm ation or fever. Interestingly, the homology between human and bacterial HSP is not random throughout the molecule. Instead, sig nificant stretches of amino acid sequence show complete identity.39 Thus it might be said that the bacterial HSP is 'studded' with mamm alian self-antigen or self-epitope.
HSP are just one of many examples of similarities between 'foreign' antigens and 'self-antigens'. Indeed the distinction may actually be rather artificial and in the final analysis, the capacity of a protein to initiate an immune response may merely be related to its immunogenicity or pathogenicity. Thus self-antigens belong to the poorly immunogenic group of proteins while certain non-self antigens (but by no means all such 'foreign' antigens) belong to the strongly immunogenic group. A consequence of the similarity between foreign and self-antigens, known in contemporary jargon as 'molecu lar mimicry' , is that if the organism mounts an immune response to a foreign protein which contains epitopes with homology to self-antigens, then activation of both foreign antigen-reactive T cells and autoreactive T cells would occur (Fig. 10) . Homology has been observed between retinal antigens and micro-organisms. For instance, there are similarities between sequences in retinal S antigen and proteins from yeast histone H3 and E. coli and also with certain viral peptides.4O-42 Infection therefore with the appropriate pathogenic strain of the organism might initiate an autoimmune response to retinal antigen pro vided a sufficiently large dose of the inoculum was pres ent. Clearly there would be a time-lag between the initial infection and the development of the ' autoimmune' ocular inflamm ation and this, in fact, is often the pattern of development of endogenous uveoretinitis.
HOMING OF ACTIVATED T CELLS TO THE EYE
The next question which must be asked is, if activation of antigen-specific T cells occurs in the periphery, how do they home in on the target organ and cause damage? In most tissues, inflammatory cells gain access to the tissue through the post-capillary venule. It has been shown that endothelial cells at these sites undergo morphological changes which resemble the phenotype of high endo thalial venules (HEV) of lymphoid tissues, cells which have a specialised function for the trafficking of lympho cytes. 43 In addition, these cells are induced to express high Model for the in duction of uveitis involving: initiation by a foreign antigen; cross-reacting epitopes with autoantigen ca usin g activation of autoantigen -specifi,c T cells; activation of blood-retinal barrier cells, with expression of adhesion molecules, during the course of the immune respon se to the foreign antigen; and 'homing' of activated autoantigen-specijic T cells to the ta rget organ e. g. the retina. BRB, blood-retinal ba rrier; F.Ag respon se,foreign antigen respon se. (Table III) Fig. 14) .
Susceptibility to autoimmune disease also depends on having the 'right' T cell receptor. Thus it has been shown Susceptibility to disease is not only dependent on having the appropriate genetic make-up but also on having the correct machinery in place to cause damage to the tis sue. The nature of the effector cell in EA U and stiIl less in human uveoretinitis, is at present unknown. While most of these organ-specific diseases, including EAU, are CD4+ T cell mediated diseases much of the damage appears to be mediated by macrophages. Indeed, the first cell to appear at the target site is the macrophage (Fig. 15a)24 and recent studies suggest that these cells may be specifically acti vated (Fig. 15b) 
CLINICAL EVIDENCE FOR AN AUTOIMMIUNE RESPONSE TO RETINAL ANTIGENS IN UVEITIS
This subject has been reviewed on several occasions pre viously and only a brief comment is included here.62. 
THERAPEUTIC CONSIDERATIONS
The theme of this lecture was autoimmune mechanisms but it would be incomplete if reference to therapy were not Figure 17 summarises some of these, In addition to the above strat egies, it might be possible to block antigen presentation using monoclonal antibodies to the MHC Class II mol ecule or to the T cell receptor; to block homing of T cells to the target organ with monoclonal antibodies to the 'adhe sion' molecules; to inhibit lymphokine production by anti bodies or drugs (the mode of action of current 'specific' therapies such as Cyclosporin A and FK506); to inhibit cytotoxic cells and activated macrophages with specific agents; and as a last resort to develop the range of anti inflammatories which can interfere with the action of the many non-specific cells at the site of tissue damage,
